American Portfolios Advisors Alaunos Therapeutics, Inc. Call Options Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding TCRT
# of Institutions
8Shares Held
106KCall Options Held
0Put Options Held
0-
Gamble Jones Investment Counsel61KShares$39,6500.0% of portfolio
-
Altium Wealth Management LLC15KShares$9,7500.0% of portfolio
-
Sawtooth Solutions, LLC14.3KShares$9,2620.0% of portfolio
-
Argi Investment Services, LLC13KShares$8,4500.0% of portfolio
-
Trustcore Financial Services, LLC250Shares$1620.0% of portfolio
About Alaunos Therapeutics, Inc.
- Ticker TCRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,182,000
- Market Cap $141M
- Description
- Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...